Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.US-based pharmaceutical company, Eli Lilly & Company has terminated its equal drug-discovery joint venture with Jubilant Life Sciences of India.
Subscribe to our email newsletter
The alliance between the two companies focused on development of molecules for a range of therapeutic areas, economictimes.indiatimes.com reported.
Jubilant Life Sciences’ wholly-owned subsidiary Jubilant Biosys has entered a 50:50 JV with Eli Lilly in late 2008.
The partnership laid emphasis on developing molecules from the pre-clinical to phase II stage spanning many areas including oncology, diabetes and cardiovascular segments.